With the launch, expected in the second quarter, "Vermillion is now poised for growth both domestically and internationally as we continue to develop our international strategy in concert with the efforts already underway in the US," its CEO said.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.